KoehneC.H., GrotheyA., BokemeyerC.: Chemotherapy in elderly patients with colorectal cancer. Ann Oncol, 12: 435–442, 2001.
2.
FentimanI.S., TirelliU., MonfardiniS.: Cancer in the elderly: why so badly treated?Lancet, 335: 1020–1022, 1990.
3.
ArriagadaR., Le ChevalierT., PignonJ.P.: Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med, 329: 1848–1852, 1993.
PazdurR., DouillardJ.Y., SkillingsJ.: Multicenter phase III study of 5fluorouracil (5FU) or UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer. Proc ASCO, 18: 263a, 1999.
7.
CarmichaelJ., PopielaT., RadstoneD.: Randomized comparative study of Orzel (oral UFT plus leucovorin) versus parenteral 5FU plus leucovorin in patients with metastatic colorectal cancer. Proc ASCO, 18: 264a, 1999.
8.
Diaz-RubioE., SastreJ., AbadA.: UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients. Oncology, 13: 35–40, 1999.
9.
FeliuJ., Gonzalez BaronM., EspinosaE.: Uracil and tegafur modulated with leucovorin. An effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group. Cancer, 79: 1884–1889, 1997.
10.
FeliuJ., CalvilloJ., EscribanoA.: Neoadjuvant therapy of rectal carcinoma with UFT-folinic acid plus radiotherapy. Proc ASCO, 19: 266a, 1999.
